|
1）Yoritaka A, Ohta K, Kishida S. Prevalence of neurological complications in Japanese patients with AIDS after the introduction of HAART. 臨床神経．2007; 47: 491-6
|
|
|
|
2）Spudich S, González-Scarano F. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med. 2012; 2: a007120
|
|
|
|
|
|
3）Croucher A, Winston A. Neurological complications of HIV. Medicine. 2013; 41: 8; 450-5
|
|
|
|
|
4）Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007; 69: 1789-99
|
|
|
|
|
|
5）Gandhi NS, Moxley RT, Creighton J, et al. Comparison of scales to evaluate the progression of HIV associated neurocognitive disorder. HIV Ther. 2010; 4: 371-9
|
|
|
|
|
|
6）Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010; 24: 1243-50
|
|
|
|
|
|
7）European Treatment Guideline.http://www.europeanaidsclinicalsociety.org/
|
|
|
|
|
|
8）三浦義治，岸田修二．HIV感染に伴う神経疾患．Brain and Nerve. 2013; 65: 275-81
|
|
|
|
|
9）Schouten J, Cinque P, Gisslen M, et al. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS. 2011; 25: 561-75
|
|
|
|
|
|
10）中川正法．HIV感染と神経合併症．Clin Neurosci. 2010; 28: 331-4
|
|
|
|
|
|
11）Jaeger LB, Nath A. Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis. Dis Models Mechanisms. 2012; 5: 313-22
|
|
|
|
|
|
12）Lackner AA, Lederman MM, Rodriguez B. HIV pathogenesis-The host. Cold Spring Harb Perspect Med. 2011; a007005
|
|
|
|
|
|
13）Xing HQ, Hayakawa H, Gelpi E, et al. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. J Neuropathol Exp Neurol. 2009; 68: 199-209
|
|
|
|
|
|
14）Xing HQ, Moritoyo T, Mori K, et al. Expression of proinflammatory cytokines and its relationship with virus infection in the brain of macaques inoculated with macrophage-tropic simian immuno-deficiency virus. Neuropathology. 2009; 29: 13-9
|
|
|
|
|
|
15）岸田修二．HAART導入後の神経系AIDSとその関連疾患—真菌性髄膜炎を含めて．Neuroinfection. 2009; 14: 78-84
|
|
|
|
|
|
16）Johnson T, Nath A. Neurological complications of immune reconstitution in HIV-infected populations. Ann N Y Acad Sci. 2010; 1184: 106-20
|
|
|
|
|
|
17）Zaffiri L, Verma R, Struzzieri K, et al. Immune reconstitution inflammatory syndrome involving the central nervous system in a patient with HIV infection: a case report and review of literature. New Microbiologica. 2013; 36: 89-92
|
|
|
|
|
|
18）Tan IL, Smith BR, von Geldern G, et al. HIV-associated opportunistic infections of the CNS. Lancet Neurol. 2012; 11: 605-17
|
|
|
|
|
|
19）McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005; 4: 543-55
|
|
|
|
|
|
20）Funata N, Maeda Y, Koike M, et al. Neuropathology of the central nervous system in acquired immune deficiency syndrome (AIDS) in Japan. With special reference to human immunodeficiency virus-induced encephalomyelopathies. Acta Pathol Jpn. 1991; 41: 206-11
|
|
|
|
|
|
21）Centner CM, Bateman KJ, Heckmann JM. Manifestations of HIV infection in the peripheral nervous system. Lancet Neurol. 2013; 12: 295-309
|
|
|
|
|
|
22）Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy: A new clinical entity. Lancet. 1986; 1: 1031-2
|
|
|
|
|
|
23）Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to HTLV-I and adult T-cell leukemia-like cells. Ann Neurol. 1987; 21: 117-22
|
|
|
|
|
|
24）Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012; 84: 327-35
|
|
|
|
|
|
25）出雲周二，松崎敏男，久保田龍二．HAMの新しい展開．神経内科．2011; 75: 369-73
|
|
|
|
|
|
26）Koga M, Takahashi T, Kawai M, et al. Neuromyelitis optica with HTLV-1 infection: different from acute progressive HAM? Intern Med. 2009; 48: 1157-9
|
|
|
|
|
27）梅原藤雄．HAMの臨床的多様性．神経内科．2011; 75: 374-9
|
|
|
|
|
|
28）山野嘉久，佐藤知雄．HTLV-1関連脊髄症(HAM)の病態・治療とバイオマーカー．日本臨牀．2013; 71: 870-5
|
|
|
|
|
|
29）武澤信夫，奥田求己，中川正法．HAMのリハビリテーション．神経内科．2011; 75: 393-401
|
|
|
|
|
|
30）Izumo S, Ijichi T, Higuchi I, et at. Neuropathology of HTLV-I-associated myelopathy-a report of two autopsy cases. Acta Paediatr Jpn. 1992; 34: 358-64
|
|
|
|
|
|
31）Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I associated myelopathy. J Neuropathol Exp Neurol. 1993; 52: 424-30
|
|
|
|
|
|
32）Umehara F, Izumo S. Takeya M, et al. Expression of adhesion molecules and monocyte chemo-attractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol (Berl). 1996; 91: 343-50
|
|
|
|
|
|
33）Moritoyo T, Reinhart TA, Moritoyo H, et al. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4＋ T lymphocytes. Ann Neurol. 1996; 40: 84-90
|
|
|
|
|
|
34）納 光弘，宇宿功市郎，梅原藤雄，他．HAMの病態と治療．日本内科学会雑誌．2003; 92: 1673-82
|
|
|
|
|
|
35）Saito M, Matsuzaki T, Satou Y, et al: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HAM/TSP. Retrovirology. 2009; 6: 19
|
|
|
|
|
|
36）Yamano Y, Araya N, Sato T, et al. Abnormally high levels of virus-infected IFN-gamma＋ CCR4＋ CD4＋ CD25＋ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One. 2009; 4: e6517
|
|
|
|
|
|
37）Araya N, Sato T, Yagishita N, et al. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease. Viruses. 2011; 3: 1532-48
|
|
|
|
|
|
38）Satou Y, Utsunomiya A, Tanabe J, et al. HTLV-1 modulates the frequency and phenotype of FoxP3＋CD4＋ T cells in virus-infected individuals. Retrovirology. 2012; 9: 46
|
|
|
|
|
|
39）Ando H, Sato T, Tomaru U, et al. Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain. 2013; 136(Pt9): 2876-87
|
|
|
|
|